|
1
|
Peddareddigari V, Wang D and Dubois RN:
The tumor microenvironment in colorectal carcinogenesis. Cancer
Microenviron. 3:149–166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molnár B, Galamb O, Péterfia B, Wichmann
B, Csabai I, Bodor A, Kalmár A, Szigeti KA, Barták BK, Nagy ZB, et
al: Gene promoter and exon DNA methylation changes in colon cancer
development-mRNA expression and tumor mutation alterations. BMC
Cancer. 18:6952018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakai E, Nakajima A and Kaneda A:
Accumulation of aberrant DNA methylation during colorectal cancer
development. World J Gastroenterol. 20:978–987. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun W, Wang X, Li J, You C, Lu P, Feng H,
Kong Y, Zhang H, Liu Y, Jiao R, et al: MicroRNA-181a promotes
angiogenesis in colorectal cancer by targeting SRCIN1 to promote
the SRC/VEGF signaling pathway. Cell Death Dis. 9:4382018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ,
Hsu CW, Chen WS and Wang JH: Linc00659, a long noncoding RNA, acts
as novel oncogene in regulating cancer cell growth in colorectal
cancer. Mol Cancer. 17:722018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taborda MI, Ramírez S and Bernal G:
Circular RNAs in colorectal cancer: Possible roles in regulation of
cancer cells. World J Gastrointest Oncol. 9:62–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pancione M, Remo A, Zanella C, Sabatino L,
Di Blasi A, Laudanna C, Astati L, Rocco M, Bifano D, Piacentini P,
et al: The chromatin remodelling component SMARCB1/INI1 influences
the metastatic behavior of colorectal cancer through a gene
signature mapping to chromosome 22. J Transl Med. 11:2972013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shirafkan N, Mansoori B, Mohammadi A,
Shomali N, Ghasbi M and Baradaran B: MicroRNAs as novel biomarkers
for colorectal cancer: New outlooks. Biomed Pharmacother.
97:1319–1330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21
as a diagnostic and prognostic biomarker in colorectal cancer. J
Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang PY, Chen CC, Chang YS, Tsai WS, You
JF, Lin GP, Chen TW, Chen JS and Chan E: MicroRNA-223 and
microRNA-92a in stool and plasma samples act as complementary
biomarkers to increase colorectal cancer detection. Oncotarget.
7:10663–10675. 2016.PubMed/NCBI
|
|
11
|
Li J, Zou K, Yu L, Zhao W, Lu Y, Mao J,
Wang B, Wang L, Fan S, Song B and Li L: MicroRNA-140 inhibits the
epithelial-mesenchymal transition and metastasis in colorectal
cancer. Mol Ther Nucleic Acids. 10:426–437. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu W, Yang J, Feng X, Wang H, Ye S, Yang
P, Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates
phosphatase and tensin homologue (PTEN) expression and promotes
growth, migration, and invasion in colorectal carcinoma cells. Mol
Cancer. 12:302013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu W, Yang P, Feng X, Wang H, Qiu Y, Tian
T, He Y, Yu C, Yang J, Ye S and Zhou Y: The relationship between
and clinical significance of MicroRNA-32 and phosphatase and tensin
homologue expression in colorectal cancer. Genes Chromosomes
Cancer. 52:1130–1140. 2013. View Article : Google Scholar
|
|
14
|
Porzycki P, Ciszkowicz E, Semik M and
Tyrka M: Combination of three miRNA (miR-141, miR-21, and miR-375)
as potential diagnostic tool for prostate cancer recognition. Int
Urol Nephrol. 50:1619–1626. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Min L, Ren C, Xu X, Yang J, Sun X,
Wang T, Wang F, Sun C and Zhang X: miRNA-148a serves as a
prognostic factor and suppresses migration and invasion through
Wnt1 in non-small cell lung cancer. PLoS One. 12:e01717512017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng Y, Wang KX, Xu H and Hong Y:
Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3,
and hsa-miR-600 as potential prognostic biomarker for cervical
cancer. J Cell Biochem. 119:1558–1566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saito Y, Friedman JM, Chihara Y, Egger G,
Chuang JC and Liang G: Epigenetic therapy upregulates the tumor
suppressor microRNA-126 and its host gene EGFL7 in human cancer
cells. Biochem Biophys Res Commun. 379:726–731. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baskerville S and Bartel DP: Microarray
profiling of microRNAs reveals frequent coexpression with
neighboring miRNAs and host genes. RNA. 11:241–247. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mekala JR, Naushad SM, Ponnusamy L,
Arivazhagan G, Sakthiprasad V and Pal-Bhadra M: Epigenetic
regulation of miR-200 as the potential strategy for the therapy
against triple-negative breast cancer. Gene. 641:248–258. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu M, Zhang N, Lu X and He S: Negative
regulation of kruppel-like Factor 4 on microRNA-106a at upstream
transcriptional level and the role in gastric cancer metastasis.
Dig Dis Sci. 63:2604–2616. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuang Q, Li J, You L, Shi C, Ji C, Guo X,
Xu M and Ni Y: Identification and characterization of NF-kappaB
binding sites in human miR-1908 promoter. Biomed Pharmacother.
74:158–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Xu Z, Li B, Zhang Z, Luo H, Wang Y,
Lu Z and Wu X: Epigenetic silencing of miRNA-9 is correlated with
promoter-proximal CpG island hypermethylation in gastric cancer in
vitro and in vivo. Int J Oncol. 45:2576–2586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang W, Ji G, Xiao X, Chen X, Qin WW, Yang
F, Li YF, Fan LN, Xi WJ, Huo Y, et al: Epigenetically regulated
miR-145 suppresses colon cancer invasion and metastasis by
targeting LASP1. Oncotarget. 7:68674–68687. 2016.PubMed/NCBI
|
|
25
|
Tagne JB, Mohtar OR, Campbell JD,
Lakshminarayanan M, Huang J, Hinds AC, Lu J and Ramirez MI:
Transcription factor and microRNA interactions in lung cells: An
inhibitory link between NK2 homeobox 1, miR-200c and the
developmental and oncogenic factors Nfib and Myb. Respir Res.
16:222015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar A, Nayak S, Pathak P, Purkait S,
Malgulawar PB, Sharma MC, Suri V, Mukhopadhyay A, Suri A and Sarkar
C: Identification of miR-379/miR-656 (C14MC) cluster downregulation
and associated epigenetic and transcription regulatory mechanism in
oligodendrogliomas. J Neurooncol. 139:23–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou YF, Fu ZY, Chen XH, Cui Y, Ji CB and
Guo XR: Tumor necrosis factor-α and interleukin-6 suppress
microRNA-1275 transcription in human adipocytes through nuclear
factor-κB. Mol Med Rep. 16:5965–5971. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao H, Zhang J, Shao H, Liu J, Jin M,
Chen J and Huang Y: Transforming growth factor β1/smad4 signaling
affects osteoclast differentiation via regulation of miR-155
expression. Mol Cells. 40:211–221. 2017.PubMed/NCBI
|
|
29
|
Sand M: The pathway of miRNA maturation.
Methods Mol Biol. 1095:3–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim YK and Kim VN: Processing of intronic
microRNAs. EMBO J. 26:775–783. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Zhang L and Sun T: Cohesive
regulation of neural progenitor development by microRNA miR-26, its
host gene ctdsp and target gene Emx2 in the mouse embryonic
cerebral cortex. Front Mol Neurosci. 11:442018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma N, Wang X, Qiao Y, Li F, Hui Y, Zou C,
Jin J, Lv G, Peng Y, Wang L, et al: Coexpression of an intronic
microRNA and its host gene reveals a potential role for miR-483-5p
as an IGF2 partner. Mol Cell Endocrinol. 333:96–101. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yeung CL, Tsang TY, Yau PL and Kwok TT:
Human papillomavirus type 16 E6 suppresses microRNA-23b expression
in human cervical cancer cells through DNA methylation of the host
gene C9orf3. Oncotarget. 8:12158–12173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lerner M, Harada M, Lovén J, Castro J,
Davis Z, Oscier D, Henriksson M, Sangfelt O, Grandér D and Corcoran
MM: DLEU2, frequently deleted in malignancy, functions as a
critical host gene of the cell cycle inhibitory microRNAs miR-15a
and miR-16-1. Exp Cell Res. 315:2941–2952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yan T, Zhang F, Sun C, Sun J, Wang Y, Xu
X, Shi J and Shi G: miR-32-5p-mediated Dusp5 downregulation
contributes to neuropathic pain. Biochem Biophys Res Commun.
495:506–511. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu C, Aragam N, Li X, Villla EC, Wang L,
Briones D, Petty L, Posada Y, Arana TB, Cruz G, et al: BCL9 and
C9orf5 are associated with negative symptoms in schizophrenia:
meta-analysis of two genome-wide association studies. PLoS One.
8:e516742013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kyuno D, Yamaguchi H, Ito T, Kono T,
Kimura Y, Imamura M, Konno T, Hirata K, Sawada N and Kojima T:
Targeting tight junctions during epithelial to mesenchymal
transition in human pancreatic cancer. World J Gastroenterol.
20:10813–10824. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo NL, Zhang JX, Wu JP and Xu YH:
Isoflurane promotes glucose metabolism through up-regulation of
miR-21 and suppresses mitochondrial oxidative phosphorylation in
ovarian cancer cells. Biosci Rep. 37(pii): BSR201708182017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li L, Geng Y, Feng R, Zhu Q, Miao B, Cao J
and Fei S: The human RNA surveillance factor UPF1 modulates gastric
cancer progression by targeting long non-coding RNA MALAT1. Cell
Physiol Biochem. 42:2194–2206. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Peng JM, Bera R, Chiou CY, Yu MC, Chen TC,
Chen CW, Wang TR, Chiang WL, Chai SP, Wei Y, et al: Actin
cytoskeleton remodeling drives epithelial-mesenchymal transition
for hepatoma invasion and metastasis in mice. Hepatology.
67:2226–2243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Spitz F and Furlong EE: Transcription
factors: From enhancer binding to developmental control. Nat Rev
Genet. 13:613–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang D, Hou T, Li L, Chu Y, Zhou F, Xu Y,
Hou X, Song H, Zhu K, Hou Z, et al: Smad1 promotes colorectal
cancer cell migration through Ajuba transactivation. Oncotarget.
8:110415–110425. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang L, Liu Z, Tan J, Dong H and Zhang X:
Multispectral imaging reveals hyper active TGF-β signaling in
colorectal cancer. Cancer Biol Ther. 19:105–112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gordziel C, Bratsch J, Moriggl R, Knösel T
and Friedrich K: Both STAT1 and STAT3 are favourable prognostic
determinants in colorectal carcinoma. Br J Cancer. 109:138–146.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu Y, Peng Y, Wu M, Zhang W, Zhang M, Xie
R, Zhang P, Bai Y, Zhao J, Li A, et al: Oncogene FOXK1 enhances
invasion of colorectal carcinoma by inducing epithelial-mesenchymal
transition. Oncotarget. 7:51150–51162. 2016.PubMed/NCBI
|
